Quantitative evaluation of the impact of relaxing eligibility criteria on the risk–benefit profile of drugs for lung cancer based on real‐world data.

Autor: Huang, Huiyao1 (AUTHOR), Jia, Shuopeng1 (AUTHOR), Wang, Xin1 (AUTHOR), Miao, Huilei1 (AUTHOR), Fang, Hong1 (AUTHOR), He, Hanqing1 (AUTHOR), Wu, Dawei1 (AUTHOR), Tang, Yu1 (AUTHOR), Li, Ning1 (AUTHOR) ncctrials@cicams.ac.cn
Zdroj: Thoracic Cancer. May2024, Vol. 15 Issue 14, p1187-1194. 8p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje